Literature DB >> 7619526

Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity.

S M Sine1, K Ohno, C Bouzat, A Auerbach, M Milone, J N Pruitt, A G Engel.   

Abstract

In five members of a family and another unrelated person affected by a slow-channel congenital myasthenic syndrome (SCCMS), molecular genetic analysis of acetylcholine receptor (AChR) subunit genes revealed a heterozygous G to A mutation at nucleotide 457 of the alpha subunit, converting codon 153 from glycine to serine (alpha G153S). Electrophysiologic analysis of SCCMS end plates revealed prolonged decay of miniature end plate currents and prolonged activation episodes of single AChR channels. Engineered mutant AChR expressed in HEK fibroblasts exhibited prolonged activation episodes strikingly similar to those observed at the SCCMS end plates. Single-channel kinetic analysis of engineered alpha G153S AChR revealed a markedly decreased rate of ACh dissociation, which causes the mutant AChR to open repeatedly during ACh occupancy. In addition, ACh binding measurements combined with the kinetic analysis indicated increased desensitization of the mutant AChR. Thus, ACh binding affinity can dictate the time course of the synaptic response, and alpha G153 contributes to the low binding affinity for ACh needed to speed the decay of the synaptic response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619526     DOI: 10.1016/0896-6273(95)90080-2

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  81 in total

1.  Activation of muscle nicotinic acetylcholine receptor channels by nicotinic and muscarinic agonists.

Authors:  G Akk; A Auerbach
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 2.  Inherited and experimentally induced changes in gating kinetics of muscle nicotinic acetylcholine receptor.

Authors:  C Bouzat; F J Barrantes
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

Review 3.  Ion channel genes and human neurological disease: recent progress, prospects, and challenges.

Authors:  E C Cooper; L Y Jan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  Ion channels in health and disease. 83rd Boehringer Ingelheim Fonds International Titisee Conference.

Authors:  B A Niemeyer; L Mery; C Zawar; A Suckow; F Monje; L A Pardo; W Stuhmer; V Flockerzi; M Hoth
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

5.  Subunit-selective contribution to channel gating of the M4 domain of the nicotinic receptor.

Authors:  Cecilia Bouzat; Fernanda Gumilar; María del Carmen Esandi; Steven M Sine
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

6.  Desensitization of diliganded mouse muscle nicotinic acetylcholine receptor channels.

Authors:  Sergio Elenes; Anthony Auerbach
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

7.  Structural elements near the C-terminus are responsible for changes in nicotinic receptor gating kinetics following patch excision.

Authors:  G Akk; J H Steinbach
Journal:  J Physiol       Date:  2000-09-15       Impact factor: 5.182

8.  Contributions of the non-alpha subunit residues (loop D) to agonist binding and channel gating in the muscle nicotinic acetylcholine receptor.

Authors:  Gustav Akk
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

9.  Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation.

Authors:  H L Wang; A Auerbach; N Bren; K Ohno; A G Engel; S M Sine
Journal:  J Gen Physiol       Date:  1997-06       Impact factor: 4.086

10.  Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit.

Authors:  M Milone; H L Wang; K Ohno; T Fukudome; J N Pruitt; N Bren; S M Sine; A G Engel
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.